8-K: Qualigen Secures $41M PIPE, Pivots to Crypto & AI with Faraday Future

Qualigen Therapeutics successfully closed a $41 million private placement led by Faraday Future, signaling a strategic transformation into a Web3and crypto-focused business.

Summary

• Qualigen Therapeutics, Inc. (NASDAQ: QLGN) completed a $41 million private investment in public equity (PIPE) financing.
• Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) was the lead investor, contributing $30 million for approximately 55% pro forma beneficial ownership.
• FF Founder and Global Co-CEO YT Jia personally invested approximately $4 million, representing about 7% ownership, with a two-year voluntary lockup.
• The financing involved the purchase of 337,432 shares of common stock at $2.246 per share and 17,783 shares of newly created Series B Convertible Preferred Stock at $1,000 per share.
• Up to $6.8 million of the net proceeds will be used to pay existing debt and fund current business operations, with the balance dedicated to establishing cryptocurrency treasury operations.
• The company plans a strategic transformation into a Web3and crypto-focused business, with an anticipated rebranding to CXC10.
• The new CXC10 business will focus on three growth engines: Crypto 10 (C10) as a Value Anchor (Digital Asset Treasury, C10 Index, potential C10 ETF), DeAI Agent (BesTrade) as an AI-powered crypto trading agent, and RWA & Ecosystem Tokens (C10 Stablecoin, EAI + Crypto Dual-Bridge RWA product).
• Stockholder approval is required for the conversion of Series B Stock into common stock, specifically for issuances exceeding the 19.99% Exchange Cap and for shares issued to certain advisors.
• The company agreed to pay Univest Securities LLC, the placement agent, a cash fee of 5.5% of gross proceeds ($2.255 million) and issue warrants to purchase 6% of the securities sold, with an exercise price of $2.47 per share, plus up to $150,000 in expenses.
• About Investment Pte. will receive approximately 60,257 shares of common stock (5% of outstanding common stock post-Closing) for capital markets advisory services.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to the significant capital infusion and a bold strategic pivot into high-growth sectors (Web3, crypto, AI). This provides a clear path for future operations and growth. However, the inherent risks of a new business model, the need for stockholder approval, and potential dilution temper the score slightly from a perfect 10.

Positives

• Secured significant capital of $41 million, providing funding for debt repayment, existing operations, and a new strategic direction.
• Established a strategic partnership with Faraday Future Intelligent Electric Inc., a publicly traded company, which includes substantial investment and management involvement.
• Initiated a bold strategic transformation into the high-growth Web3, crypto, and AI sectors, potentially opening new revenue streams and market opportunities.
• The Lead Investor (Faraday Future) has committed to a two-year voluntary lockup for a portion of its investment, indicating long-term commitment.
• The company will adopt a treasury reserve policy suitable to the Lead Investor, suggesting a structured approach to its new crypto operations.
• Voting Stockholders (holders of Series A-2 Convertible Preferred Stock) have agreed to vote in favor of the necessary Stockholder Approval, increasing the likelihood of the Series B conversion proceeding.

Negatives

• The conversion of Series B Preferred Stock and issuance of certain shares are contingent on obtaining Stockholder Approval, which introduces a potential delay or uncertainty.
• Significant fees and warrants are being paid to the placement agent (5.5% cash fee and 6% warrants), which will dilute existing shareholders.
• Issuance of approximately 60,257 shares of common stock to an advisor (About Investment Pte.) for services will also contribute to shareholder dilution.
• The strategic pivot into Web3, crypto, and AI is a significant departure from the company's existing business and carries inherent risks associated with new, volatile, and rapidly evolving markets.
• The company faces risks related to regaining and maintaining compliance with Nasdaq's continued listing requirements, including timely filing of financial reports, with potential de-listing if not met.

Risks

• Ability to regain and maintain compliance with Nasdaq's continued listing requirements, including the timely filing of its Form 10-Q for the period ended September 30, 2024.
• Potential de-listing of the company's shares from The Nasdaq Capital Market due to failure to comply with listing requirements.
• Uncertainty of future events or outcomes related to forward-looking statements, which may turn out to be wrong or affected by incorrect assumptions or unknown risks.
• Risks inherent in the new Web3, crypto, and AI business adventure, which are volatile and rapidly evolving markets.
• Reliance on obtaining Stockholder Approval for the full conversion of Series B Stock and issuance of certain shares, which if not obtained, could impact the financing structure.

Future Outlook

The company plans to rebrand as CXC10 soon and establish itself as a top U.S. public company bridging Web2 and Web3, as well as AI and crypto. Its new business will center on three growth engines: Crypto 10 (C10) as a Value Anchor, DeAI Agent (BesTrade), and RWA & Ecosystem Tokens, aiming to pioneer new economic models connecting AI, crypto, and traditional sectors.

Management Comments

• "Completion of the financing marks a pivotal moment in Qualigen's history, which provides the capital, strategic support, and leadership required to initiate a bold transformation of our company." Kevin Richardson, Co-CEO of QLGN.
• "Moving forward, we will sharpen our strategic focus, strengthen technical capabilities, and embrace an open ecosystem approach as we strive toward our goal." Kevin Richardson, Co-CEO of QLGN.

Industry Context

This announcement reflects a growing trend of traditional companies exploring or pivoting into the digital asset and Web3 space, often driven by the potential for new growth vectors and technological innovation. The integration of AI with crypto, as proposed by CXC10's DeAI Agent, aligns with the broader industry convergence of these two transformative technologies. The involvement of a company like Faraday Future, known for its electric vehicle technology, in a crypto venture highlights the increasing cross-industry interest in blockchain and digital assets. The focus on Real World Assets (RWA) and stablecoins also positions the company within a key area of development in the Web3 ecosystem, aiming to bridge traditional finance with decentralized finance.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess the $41 million PIPE financing or the strategic pivot against global benchmarks. However, the move into Web3, AI, and crypto is a significant strategic shift, common among companies seeking to capitalize on emerging technologies, though the success rate and valuation multiples vary widely across the industry.
• The valuation implied by the common stock purchase price of $2.246 per share would need to be compared against peer companies in the biotech sector (Qualigen's former primary focus) and emerging Web3/AI companies to determine its competitiveness, which is not provided in the filing.

Management Changes

Corporate Governance

Related Party Transactions

• Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI), the Lead Investor, invested $30 million in the private placement. YT Jia, FF's Founder and Global Co-CEO, personally invested approximately $4 million.
• Jerry Wang, President of FF, was appointed Co-CEO of Qualigen. Koti Meka, CFO of FF, was appointed CFO of Qualigen.
• YT Jia will serve as Chief Advisor to Qualigen.
• The Lead Investor Agreement grants Faraday Future significant rights regarding Board appointments, treasury policy, and participation in future financings.

Stakeholder Impact

• **Shareholders**: Potential for significant dilution from the issuance of common stock, convertible preferred stock, and warrants. However, the capital raise and strategic pivot could lead to substantial long-term value creation if the new crypto/AI business is successful. Existing shareholders will have a vote on the Series B conversion and related share issuances.
• **Employees**: A major strategic shift implies a change in focus and potentially skill sets required. New management appointments from Faraday Future will influence corporate culture and direction.
• **Customers**: The company's existing business will continue, but the primary focus will shift to the new CXC10 crypto/AI ventures, potentially impacting resource allocation for existing product lines.
• **Creditors**: Up to $6.8 million of the proceeds will be used to pay existing debt, which is positive for creditors as it reduces financial risk.
• **Management**: Significant changes in the executive team and Board composition, with new Co-CEO, CFO, and Chief Advisor, and Board designees from the Lead Investor, indicating a new leadership structure and strategic direction.

Next Steps

• Obtain Stockholder Approval for the conversion of Series B Stock and issuance of certain shares by October 29, 2025 (or November 28, 2025, if SEC review occurs).
• File a registration statement for the resale of Common Stock and Conversion Shares within 45 days of the closing.
• Work to have the resale registration statement declared effective within 45 days of filing (or 60 days if SEC conducts a full review).
• Establish the company's cryptocurrency treasury operations.
• Rebrand the company as CXC10.
• Develop and launch the new CXC10 crypto business, including the C10 Digital Asset Treasury, C10 Index, potential C10 ETF, DeAI Agent (BesTrade), C10 Stablecoin, and EAI + Crypto Dual-Bridge RWA product.
• Adopt a treasury reserve policy suitable to the Lead Investor.
• Integrate new management (Co-CEO Jerry Wang, CFO Koti Meka) and Board designees from the Lead Investor.

Key Dates

Recommendation

The $41 million capital raise and strategic pivot into Web3, crypto, and AI are significant developments that could fundamentally alter the company's risk-reward profile. While the capital infusion is a positive, the new business model is highly speculative and operates in a volatile, rapidly evolving market. The success of this transformation is unproven, and there are execution risks, including the need for stockholder approval and the ability to navigate Nasdaq listing requirements. A 'hold' recommendation is appropriate for a seasoned investor, acknowledging the potential upside from the strategic shift and new capital, but also recognizing the high risks and uncertainties associated with entering a new, unproven business area. Investors should monitor the progress of the new CXC10 initiatives, the successful obtainment of stockholder approval, and the company's ability to execute its new strategy before making a more definitive investment decision.

Keywords

Qualigen Therapeutics, Faraday Future, PIPE financing, Web3, Crypto, AI, CXC10, Digital Asset Treasury, DeAI Agent, RWA, Nasdaq, Private Placement, Convertible Preferred Stock, Strategic Transformation